Med. 26, 193–199 . 12.Hogan, S.A., Courtier, A., Cheng, P.F., Jaberg-Bentele, N.F., Goldinger, S.M., Manuel, M., Perez, S., Plantier, N., Mouret, J.-F., Nguyen-Kim,T.D.L., et al. (2019). Peripheral Blood TCR Repertoire Proﬁling May Facil-itate Patient Stratiﬁcation for Immunotherapy against Melanoma. CancerImmunol. Res. 7, 77–85 . 13.Hopkins, A.C., Yarchoan, M., Durham, J.N., Yusko, E.C., Rytlewski, J.A., Robins, H.S., Laheru, D.A., Le, D.T., Lutz, E.R., and Jaffee, E.M. (2018).T cell receptor repertoire features associated with survival in immuno-therapy-treated pancreatic ductal adenocarcinoma. JCI Insight 3, e122092 . 14.Valpione, S., Galvani, E., Tweedy, J., Mundra, P.A., Banyard, A., Middle- hurst, P., Barry, J., Mills, S., Salih, Z., Weightman, J., et al. (2020). Im- mune-awakening revealed by peripheral T cell dynamics after one cycleof immunotherapy. Nat.